Literature DB >> 6144008

Intrathecal baclofen alleviates spinal cord spasticity.

R D Penn, J S Kroin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6144008     DOI： 10.1016/s0140-6736(84)91487-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  36 in total

Review 1.  Intrathecal drug administration. Present use and future trends.

Authors:  J S Kroin
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 2.  Imaging evaluation of intrathecal baclofen pump-catheter systems.

Authors:  A C Miracle; M A Fox; R N Ayyangar; A Vyas; S K Mukherji; D J Quint
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-28       Impact factor: 3.825

3.  Objective assessment of gait after intrathecal baclofen in hereditary spastic paraplegia.

Authors:  S Klebe; H Stolze; F Kopper; D Lorenz; R Wenzelburger; G Deuschl; J Volkmann
Journal:  J Neurol       Date:  2005-03-14       Impact factor: 4.849

4.  Intrathecal baclofen for spasticity in primary lateral sclerosis.

Authors:  Jerônimo Buzetti Milano; Mauricio Coelho Neto; Sonival Cândido Hunhevicz; Walter Oleschko Arruda; Ricardo Ramina; Erasmo Barros
Journal:  J Neurol       Date:  2005-03-29       Impact factor: 4.849

Review 5.  Complex Regional Pain Syndrome, Current Concepts and Treatment Options.

Authors:  Ivan Urits; Abra H Shen; Mark R Jones; Omar Viswanath; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2018-02-05

6.  Clinical and neurophysiologic assessment of strength and spasticity during intrathecal baclofen titration in incomplete spinal cord injury: single-subject design.

Authors:  Mark Bowden; Dobrivoje S Stokic
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

7.  Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.

Authors:  D Dressler; S Berweck; A Chatzikalfas; M Ebke; B Frank; S Hesse; M Huber; J K Krauss; K-H Mücke; A Nolte; H-D Oelmann; P W Schönle; M Schmutzler; H Pickenbrock; C Van der Ven; N Veelken; M Vogel; T Vogt; F Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2015-07-16       Impact factor: 3.575

8.  Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen.

Authors:  J Dressnandt; B Conrad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

9.  Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump.

Authors:  V Patterson; M Watt; D Byrnes; D Crowe; A Lee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

10.  Intrathecal baclofen: Its effect on symptoms and activities of daily living in severe spasticity due to spinal cord injuries: A pilot study.

Authors:  Yogendrasinh Jagatsinh
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.